IOL type determines complications in phakic surgery

Article

The type of phakic IOL chosen strongly governs the type of complication that is likely to occur in the long-term. Posterior, angle-supported anterior and iris supported anterior phakic IOLs all have different issues that face the surgeon.

The type of phakic IOL chosen strongly governs the type of complication that is likely to occur in the long-term. Posterior, angle-supported anterior and iris supported anterior phakic IOLs all have different issues that face the surgeon.

"I'm not going to deal with in surgery complications because that's specifically to do with surgical technique, which we all need to work on constantly, " said Dr Antonio Marinho. "I'm not going to focus on those complications, but on the long-term issues that are IOL-related. "

For angle-supported phakic IOLs, for example, Dr Marinho notes that most complications relate to sizing and rotation, decentration or pupil distortion.

Complications of iris-supported phakic IOLs include pigment deposits in a few cases and, exceptionally, a mild uveitis, due to excessive manipulation during surgery. "In this surgery, decentration and luxation are signs of poor surgical technique, " Dr. Marinho noted.

Posterior-chamber phakic IOLs have long been associated with the development of cataract because of their close proximity to the natural lens, he told the audience.

"With a short IOL, you get a small vault, with a danger of cataract. With a long IOL, you get excessive vault, with a danger of pigment dispersion glaucoma. With the PRL, there might be a risk of migration into the vitreous, " he said.

There are many potential complications with phakic IOLs but good surgical technique and careful biometry can avoid most of them, he concluded.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.